Challenges of Comparative Effectiveness Research with Observational Data
Capsules, liposomal liquids, sublingual tabs, NAC precursors
2024 DOI: 10.1038/s41591-024-03018-2 PMID: 38858523 Read on PubMed Cell Metabolism LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Coskun T, Urva S, Roell WC, et al
Below are some comments questions: 1
Entre los efectos adversos relacionados con la prdida de peso se incluyen riesgo de colelitiasis/colecistitis y, en pacientes con diabetes y retinopata preexistente, posible progresin de retinopata diabtica con semaglutida
Piezoelectricity and prostate cancer: proposed interaction between electromagnetic field and prostatic crystalloids